title: In Reply: Dr. Burwick.
authors.affiliation: Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
authors.forename: Emily S
authors.initials: ES
authors.lastname: Miller
authors.forename: William A
authors.initials: WA
authors.lastname: Grobman
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D002437:Cefazolin / Q000008:administration & dosage*; D023802:Cerclage, Cervical; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use*; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D011247:Pregnancy
chemical_list: D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D002437:Cefazolin; D007213:Indomethacin